Contact Support: 512-708-4678

Newsletter

GET THE BUZZ ON CONTINUING MEDICAL EDUCATION COURSES
New Course Alerts and CME News

HIV: Core
Vindico Medical Education

Richmond, VA
Feb 18, 2016

Approximately half of patients with HIV do not remain on their initial HIV treatment regimens. The US Department of Health and Human Services treatment guidelines for HIV offer detailed information to assist in the creation of durable regimens for patients with HIV. Attaining durability of response to antiretroviral therapy (ART) is multifactorial and depends on the regimen’s efficacy and tolerability. In order to make the best use of existing and future agents, it is crucial that clinicians become fully acquainted with ART characteristics and the most up-to-date published guidelines for their use. Poor adherence is the principal reason for HIV-related mortality, and health care providers must be knowledgeable about the factors leading to poor adherence in order to devise strategies to overcome them. The purpose of this unique HIV CORE initiative is to provide specific, targeted educational opportunities for clinicians who are involved in the management of patients with HIV. This CME activity will review evidence-based guidelines and factors to consider when selecting first-line treatment regimens to improve durability of response. This activity will also explore strategies to select therapeutic regimens that improve patient adherence to treatment and that are less likely to induce viral resistance.

Upon successful completion of this educational activity, participants should be better able to:

  • Review the convenience, tolerability, and toxicity of antiretroviral therapy for HIV to improve patient adherence to treatment.
  • Select therapeutic regimens that improve patient adherence to treatment and that are less likely to induce viral resistance.
  • Compare the ability of different antiretroviral agents to maintain long-term viral suppression under real-world conditions, including suboptimal patient adherence.


The intended audience for the activities is infectious disease physicians, internal medicine physicians, primary care practitioners, physician assistants, nurse practitioners, and other health care professionals involved in the treatment of patients with human immunodeficiency virus (HIV).

Please click here for information about the Richmond, VA meeting.

There is no fee to register for this activity. 

Please click here to register.


Purdue University is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Purdue University designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

Faculty, topics, program schedule, and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program committee.